| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $2.83 ▲ +1.77% | Yesterday | $2.76 ▼ -0.74% | Tomorrow's Nautilus Biotechnology Inc. Common Stock (NAUT) setup is anchored to $2.78 and targets $2.83 (+1.77%). The near-term read is upside; watch $2.86 / $2.70 because daily realized volatility is about 8.00%. |
Tomorrow's Nautilus Biotechnology Inc. Common Stock (NAUT) setup is anchored to $2.78 and targets $2.83 (+1.77%). The near-term read is upside; watch $2.86 / $2.70 because daily realized volatility is about 8.00%. | ||||
| Week | $2.93 ▲ +5.50% | Last Week | $2.72 ▼ -2.31% | The 7-day Nautilus Biotechnology Inc. Common Stock model moves from $2.72 to $2.93 (+5.50%). It gives upside momentum context for this stock, so breaks around $2.86 / $2.70 matter more than a single tick. |
The 7-day Nautilus Biotechnology Inc. Common Stock model moves from $2.72 to $2.93 (+5.50%). It gives upside momentum context for this stock, so breaks around $2.86 / $2.70 matter more than a single tick. | ||||
| Month | $3.11 ▲ +11.71% | Last Month | $2.64 ▼ -4.92% | The 1-month Nautilus Biotechnology Inc. Common Stock target is $3.11 (+11.71%), compared with the live reference near $2.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month Nautilus Biotechnology Inc. Common Stock target is $3.11 (+11.71%), compared with the live reference near $2.78. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $3.36 ▲ +21.03% | Last Year | $2.53 ▼ -8.83% | The 1-year Nautilus Biotechnology Inc. Common Stock scenario points to $3.36 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year Nautilus Biotechnology Inc. Common Stock scenario points to $3.36 (+21.03%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $3.97 ▲ +42.86% | 5 Years Ago | $2.28 ▼ -18.00% | The 5-year Nautilus Biotechnology Inc. Common Stock view is $3.97 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year Nautilus Biotechnology Inc. Common Stock view is $3.97 (+42.86%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $2.78 | Mid |
| Daily Change | -6.08% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 70% | Above |
| Data Source | nasdaq-screener | Mid |
| Current | $2.78 | Daily Change | -6.08% |
| Market Cap | $351.85M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.